Insulin resistance was assessed by the homeostasis model assessment for insulin resistance (HOMA-IR).
Insulin resistance was assessed by the homeostasis model assessment for insulin resistance (HOMA-IR) method in nondiabetic participants (24).
We assessed the insulin resistance by the homeostasis model assessment for insulin resistance (HOMA-IR) in 68 patients without insulin injections.
Lp(a), homeostasis model assessment for insulin resistance (HOMA-IR) and conventional risk factors for diabetes were assessed in a sample of 1,030 adult individuals participating in a cross-sectional population-based epidemiological survey in the city of Telde.
Fasting glucose to insulin ratio (FG:I ratio), insulin area under the curve (AUCinsulin) during OGTT, and homeostasis model assessment for insulin resistance (HOMA-IR) were calculated.
No significant difference in insulin response, whole-body insulin sensitivity, or homeostasis model assessment for low-dose, high-dose, or low- vs high-dose treatments was found.
The HOMA-IR (Homeostasis Model Assessment for Insulin Resistance) was estimated as previously reported23 and a HOMA-IR>3.2 was considered as indicative of insulin resistance.22 Lipid profile analysis included fasting plasma triglycerides and total-, low-density lipoprotein and low-density lipoprotein cholesterol.
homeostasis model assessment for insulin resistance.
After model assessment for both analyses (descriptors and triggers), three-class models were determined to have the best fit for these data.
For the modeling and analysis of EC, only monthly data were available and used in this study, which might not be sufficient for accurate modeling and model assessment, for monthly data may not include all extreme conditions.
The homeostatic model assessment for insulin resistance was calculated from insulin and glucose concentrations [37].
